+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain



Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain



Acta Psychiatrica Scandinavica. Supplementum 360: 48-49



The efficacy, tolerability and safety of moclobemide were compared with those of clomipramine in a double-blind, randomized parallel group study over 4 weeks. Patients were suffering from various forms of depression: 33 received moclobemide and 31 clomipramine. The mean score on the Hamilton Rating Scale for Depression decreased gradually in both groups, with no significant differences between them; the final scores showed an improvement of 57% in the moclobemide group and 60% in the clomipramine group, compared with baseline. The investigators' assessment of efficacy at the end of treatment was good or very good for 60% of moclobemide patients and 50% of clomipramine patients, and tolerance was good or very good for 31 patients on moclobemide and 26 on clomipramine. The drugs thus showed comparable antidepressant efficacy, and both were mostly well tolerated, although adverse events were more prevalent in patients treated with clomipramine.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040711164

Download citation: RISBibTeXText

PMID: 2248070


Related references

Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 50-51, 1990

Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression. Acta Psychiatrica Scandinavica 84(6): 564-570, 1991

Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial. British Journal of Psychiatry 160: 519-524, 1992

Moclobemide and clomipramine in the treatment of depression. A randomized clinical trial. Acta Psychiatrica Scandinavica 70(3): 254-260, 1984

Moclobemide versus clomipramine in the treatment of depression: a single-centre study, Federal Republic of Germany. Acta Psychiatrica Scandinavica. Supplementum 360: 46-47, 1990

An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression. Australian and New Zealand Journal of Psychiatry 26(3): 454-458, 1992

Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 42, 1990

Moclobemide Versus Clomipramine in Endogenous Depression. British Journal of Psychiatry 160(4): 519-524, 1992

Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 52-53, 1990

Moclobemide versus clomipramine in nonmelancholic, nonpsychotic major depression. Acta Psychiatrica Scandinavica. 92(4): 260-265, 1995

Moclobemide and clomipramine in endogenous depression. A randomized clinical trial. Acta Psychiatrica Scandinavica 79(6): 523-529, 1989

Multicenter double-blind randomized parallel-group clinical trial of effectiveness of the combination clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar major depression. European Neuropsychopharmacology 10(Suppl. 3): S249, 2000

Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression. Journal of Affective Disorders 76(1-3): 191-200, 2003

Moclobemide and clomipramine in reactive depression. A placebo-controlled randomized clinical trial. Acta Psychiatrica Scandinavica 79(6): 530-536, 1989

Orthostatic side effects of clomipramine and moclobemide during treatment for depression. Nordic Journal of Psychiatry 59(4): 298-301, 2005